ZURA PEER ANALYSIS

Zura Bio Limited Class A Ordinary Shares — metric-by-metric comparison with peers and the industry median

ZURAZura Bio Limited Class A Ordinary Shares

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ZURAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ZURA	MSB	TLX	RTALB	CSL	Ind. Median
P/E	—	—	—	4.89●	30.02	17.81
P/B	2.77	—	6.56	0.61●	2.24	3.49
EV/EBITDA	—	—	123.31	74.61	10.37●	14.92
P/S	—	31.91	3.34	6.67	2.67●	10.89

Financial Health
Metric	ZURA	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	19.33●	—	1.43	1.21	2.57	5.90
Debt/Equity	—	—	112.3%	1.2%●	67.4%	10.9%
NetDebt/EBITDA	—	—	13.13	0.90●	2.22	1.15

Profitability
Metric	ZURA	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	—	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	-42.5%	-11.3%	-1.8%	15.1%●	7.7%	-47.5%
ROA	-37.6%	-8.6%	-0.7%	13.1%●	3.8%	-35.8%
EBITDA Margin	—	-76.6%	3.0%	9.0%	32.8%●	-105.8%

Growth + Dividend
Metric	ZURA	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	-100.0%	410.4%●	56.3%	24.0%	4.8%	5.1%
NI Growth	—	—	—	134.0%●	-39.4%	12.1%
Div. Yield	—	0.0%	—	0.0%	2.5%●	0.2%
Payout	—	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	ZURA	MDXG	OMER	DNA	ARVN	PRTA	Ind. Median
P/E	—	19.68	—	—	—	—	17.81
P/B	2.77	2.49	-10.37●	1.36	1.40	1.64	3.49
EV/EBITDA	—	8.07	—	—	—	—	14.92
P/S	—	1.55●	—	4.26	6.05	8.87	10.89

Financial Health
Metric	ZURA	MDXG	OMER	DNA	ARVN	PRTA	Ind. Median
Current Ratio	19.33●	5.39	3.03	5.15	5.44	10.43	5.90
Debt/Equity	—	7.2%	-490.5%●	92.7%	2.2%	2.4%	10.9%
NetDebt/EBITDA	—	-2.48●	—	-0.18	2.80	4.31	1.15

Profitability
Metric	ZURA	MDXG	OMER	DNA	ARVN	PRTA	Ind. Median
Net Margin	—	7.9%●	—	-215.4%	-247.5%	-260.9%	-125.7%
ROE	-42.5%	13.8%●	—	-55.8%	-42.3%	-40.3%	-47.5%
ROA	-37.6%	10.6%●	—	-26.2%	-26.8%	-35.8%	-35.8%
EBITDA Margin	—	14.7%●	—	-149.2%	-242.2%	-129.0%	-105.8%

Growth + Dividend
Metric	ZURA	MDXG	OMER	DNA	ARVN	PRTA	Ind. Median
Rev. Growth	-100.0%	10.5%●	—	-40.5%	-79.1%	-58.0%	5.1%
NI Growth	—	-23.6%	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ZURA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.